Ribociclib Alternatives Compared
Ribociclib | Palbociclib | Enhertu |
|
---|
Ribociclib | Palbociclib | Enhertu (fam-trastuzumab deruxtecan) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Breast Cancer - Metastatic, Breast Cancer. ribociclib may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Breast Cancer - Metastatic, Liposarcoma, Breast Cancer, Breast Cancer - Male. palbociclib may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Breast Cancer - Metastatic, Non Small Cell Lung Cancer, Solid Tumors, Gastric Cancer, Breast Cancer. Enhertu may also be used for purposes not listed in this medication guide. |
||||||||
More about Ribociclib | More about Palbociclib | More about Enhertu (fam-trastuzumab deruxtecan) | ||||||||
Ratings & Reviews | ||||||||||
Ribociclib has an average rating of 8.3 out of 10 from a total of 30 ratings on Drugs.com. 81% of reviewers reported a positive effect, while 7% reported a negative effect. |
Palbociclib has an average rating of 6.9 out of 10 from a total of 98 ratings on Drugs.com. 63% of reviewers reported a positive effect, while 29% reported a negative effect. |
Enhertu has an average rating of 7.9 out of 10 from a total of 22 ratings on Drugs.com. 70% of reviewers reported a positive effect, while 5% reported a negative effect. |
||||||||
Drug Class | ||||||||||
Side Effects | ||||||||||
See also: ribociclib side effects in more detail. |
See also: palbociclib side effects in more detail. |
See also: Enhertu side effects in more detail. |
||||||||
Generic Availability | ||||||||||
N/A |
N/A |
N/A |
||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Enhertu prices |
||||||||
Dosage Forms Available | ||||||||||
N/A |
N/A |
|
||||||||
Brand Names | ||||||||||
Kisqali | Ibrance |
N/A |
||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||
54.7 hours |
29 hours |
136.8 hours |
||||||||
CSA Schedule ** View glossary of terms | ||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | ||||||||||
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
Drug Interactions | ||||||||||
A total of 711 drugs are known to interact with ribociclib:
|
A total of 459 drugs are known to interact with palbociclib:
|
A total of 167 drugs are known to interact with Enhertu:
|
||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||
|
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | ||||||||||
First Approval Date | ||||||||||
N/A |
N/A |
N/A |
||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||
N/A |
N/A |
N/A |
||||||||
More Information | ||||||||||
Patient resources | ||||||||||
Professional Resources | ||||||||||
Related Treatment Guide | ||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.